ParaquatIntoxication.ppt
Download
Report
Transcript ParaquatIntoxication.ppt
Paraquat intoxication
INTRODUCTION —
Paraquat (1,1-dimethyl-4,4'-bipyridylium
chloride) (since 1962)
completely denatured upon contact with the
earth
PREPARATIONS —
liquid concentrate (29 percent)
dissolved in water (2.5 to 10 percent)
aerosol (0.2 percent).
估計的致死劑量(lethal dose):在成人約為2到4克
(=20%的巴拉刈溶液食入10到20毫升)
農藥生產商在巴拉刈農藥中添加催吐劑,可引起中毒
者早期的嘔吐,以減少吸收。
台灣常見的產品種類包括:24﹪的速草淨(正豐)、
綜免刈(功力)、全草滅日農、巴拉刈、草蕪松(興
農)、克無蹤以及42﹪的巴達刈
TOXICITY AND
METABOLISM —
herbicidal activity :
by inhibiting the reduction of NADP to
NADPH during photosynthesis
→ superoxide, singlet oxygen, hydroxyl, and
peroxide radicals
→ destroy lipid cell membranes by
polymerization of unsaturated lipid
compounds
→ oxidative destruction
→ recruitment of inflammatory cells
→ late and irreversible pulmonary fibrosis
In Vivo
pulmonary toxicity : highest oxygen tensions
(alveoli) found in the body.
kidney toxicity : acute tubular necrosis (within
24 hours) → enhancing overall toxicity.
口服的巴拉刈僅有5到10%會經由腸胃道被吸
收,其餘部分由糞便排出。
巴拉刈於腸胃道的吸收相當快速,約於0.5至2
小時內即達到血中濃度的高峰
林口腎臟科 許翔皓
腎臟--第三個小時即達到頂點 / 最主要的排泄器官。
肺臟,多胺系統(polyamine system)主動運輸的方
式累積在肺泡細胞內 : 第五至七個小時之後,肺的巴
拉刈濃度會是所有身體的器官中最高的。
腎臟功能正常,百分之八十至九十的巴拉刈都會在6小
時內從尿液中排出,在24小時以內則幾乎百分之百都
會由腎臟排出。
腎功能不正常,則巴拉刈的排泄會受到很大的影響,
組織中(尤其是肺臟)和血液中的巴拉刈濃度將大幅
增高,且其濃度將延遲到15至20小時之後才達到頂點,
甚至於存留體內更長的時間。
ameliorate the toxic effects of paraquat:
deferoxamine (Complexes with trivalent ions (ferric ions) to form
removal of iron) : Lipid
peroxidation may be enhanced by iron radicals.
Vitamin E (a potent antioxidant) : only in cultured
cells ; no clinical effect
Exogenous glutathione and n-acetylcysteine, a donor
of glutathione, may protect against injury.
Sulfite or thiosulfite (redox agents) (reversing
oxidized glutathione).
ferrioxamine, removed by the kidneys
CLINICAL EXPOSURE —
Skin and lungs —infrequently results in systemic
toxicity
0.4 percent of a topical dose was absorbed from an
unoccluded site;
1.4 percent was absorbed from an occluded site; and
3.8 percent was absorbed from an occluded and
damaged dermal site [13].
thermal-dependent conversion of paraquat to non-toxic
bipyridines.
GI tract —cause systemic toxicity + direct injury to
the gastrointestinal tract
CLINICAL TOXICITY —
due to absorption via the gastrointestinal tract.
Direct local toxicity
Systemic toxicity — results from the oral
ingestion
Direct local toxicity
GI tract — result from the caustic properties of
paraquat:
1. Within a few minutes to hours → a burning
sensation in the buccal cavity.
2. within one to two days → Ulceration of the lips,
tongue, and pharynx ("pseudomembrane") →
esophageal perforation.
Skin — skin rashes (particularly on scrotal and
intergluteal areas), cracked nails, and epistaxis
Lungs —hemoptysis.
Eyes — Corneal ulceration and scarring.
Systemic toxicity — results from the
oral ingestion
Ingestion of moderate amounts — oral
ingestion of amounts of paraquat
approximately between 4 to 30 mL/kg of the
liquid concentrate:
Ingestion of massive amounts — greater
than 30 mL/kg or 50 mL of concentrate.
Ingestion of moderate amounts —
Buccal and/or esophageal ulcerations.
Renal failure (within two to six days) -
Proximal tubule dysfunction.
Metabolic acidosis-- ∵myocardial failure
(myocarditis+ epicardial hemorrhage with
arrhythmias), adrenal gland insufficiency (due
to necrosis), systemic hypotension, severe
hypoxemia, and/or renal failure.
Ingestion of moderate amounts —
Pulmonary edema (24 to 48 hours after ingestion) →
adult respiratory distress syndrome (first week after
ingestion) : diffuse consolidation,
pneumomediastinum with or without pneumothorax
and subcutaneous emphysema, and cardiomegaly
with widened superior mediastinum→ pulmonary
fibrosis.
喘的出現時間相對上會較晚,約在中毒後第3至14天才
逐漸出現
Death usually occurs within one to two weeks, but
may be observed up to six weeks after ingestion.
LABORATORY DETECTION —
A qualitative urine test for paraquat :
concentrations of 1 mg/mL or above (1 ppm)
Gas chromatography and high pressure liquid
chromatography : levels of 0.1 to 0.2 mg/dL.
Radioimmunoassay : levels well below 0.1
mg/mL.
Association with prognosis —
Fatal outcomes : plasma levels > 0.2 mg/mL
at 24 hours after ingestion / 0.1 mg/mL at 48
hours.
TREATMENT —
Prevention of gastrointestinal
absorption —
Removal from blood —ineffective in
removing paraquat → maintenance of renal
function
Ancillary treatment —
Prevention of gastrointestinal
absorption —
Gastric lavage : performed cautiously in view of
possible ulceration of the pharynx and the esophagus
diatomaceous clays(=bentonite + Fuller's earth 30%
suspension)+ magnesium sulfate, to produce a
catharsis.
bentonite in a 6 to 7.5 percent suspension
suspensions of activated charcoal
the ion-exchange resin sodium resonium
(Kayexalate®)
Total gut lavage
polyethylene glycol solutions for bowel irrigation
Removal from blood —maintenance
of renal function
Extracorporeal removal —
(moderate to low dose 4 to 30 mL/kg) : hemoperfusion within 12
hours of poisoning may reduce mortality > hemodialysis. -- up to
two to three weeks after an ingestion
charcoal hemoperfusion more rapid reduction in plasma
concentrations.
a new zeolite resin tested in vitro shows promise of a high
degree of adsorption, although it has not yet been used clinically
血液灌注應儘快於巴拉刈中毒12小時內執行,黃金時間為食入6
小時內。必須24小時內做血液灌注才有臨床意義,超過24小時則
因巴拉刈皆已被肺、肌肉等組織所吸收及累積,此時移除血液中
少量緩慢釋出的巴拉刈分子效果相當有限。
Ancillary treatment —
Immunosuppression — use of cyclophosphamide
combined with corticosteroids:
Nitric oxide (not an established therapy, case
report) — addition of nitric oxide (NO 25 ppm) to
inspired gases→ transient improvement in arterial
oxygenation in a single case report. In this,
Deferoxamine —Complexes with trivalent ions (ferric
ions) to form ferrioxamine, which are removed by the
kidneys
Pulmonary transplantation —without success
SUMMARY AND
RECOMMENDATIONS —
ingested greater than 4 mL/kg of paraquat
concentrate administration of intestinal decontaminants + daily
four to six hour hemoperfusion (or high efficiency
hemodialysis) sessions.
Daily hemoperfusion or hemodialysis treatment × 2~3
weeks. until paraquat is no longer detectable in blood.
Low-inspired oxygen therapy should be given until it
becomes impractical in the face of hypoxemia.
The administration of steroids and cyclophosphamide
may be considered.
More unconventional therapy with deferoxamine and
nitric oxide inhalation may also prove useful.